832
Views
7
CrossRef citations to date
0
Altmetric
Review

Perioperative management of Parkinson’s disease

, &
Pages 301-308 | Received 02 May 2016, Accepted 22 Sep 2016, Published online: 03 Oct 2016

References

  • Moug SJ, Stechman M, McCarthy K, et al. Frailty and cognitive impairment: unique challenges in the older emergency surgical patient. Ann R Coll Surg Engl. 2016;98(3):165–169.
  • Huang YF, Chou Y-C, Yeh -C-C, et al. Outcomes after non-neurological surgery in patients with Parkinson’s disease: a nationwide matched cohort study. Medicine (Baltimore). 2016;95(12):e3196.
  • Weintraub D, Chiang C, Kim HM, et al. Association of antipsychotic use with mortality risk in patients with Parkinson disease. JAMA Neurol. 2016;73(5):535–541.
  • Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. Jama. 1985;254(19):2792–2795.
  • Granner MA, Wooten GF. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin Neurol. 1991;11(3):228–235.
  • Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol. 2010;67(1):58–63.
  • Wullner U, Kassubek J, Odin P, et al. Transdermal rotigotine for the perioperative management of Parkinson’s disease. J Neural Transm (Vienna). 2010;117(7):855–859.
  • Korczyn AD, Reichmann H, Boroojerdi B, et al. Rotigotine transdermal system for perioperative administration. J Neural Transm (Vienna). 2007;114(2):219–221.
  • Broussolle E, Marion M, Pollak P. Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery. The Lancet. 1992;340(8823):859–860.
  • Slotty PJ, Wille C, Kinfe TM, et al. Continuous perioperative apomorphine in deep brain stimulation surgery for Parkinson’s disease. Br J Neurosurg. 2014;28(3):378–382.
  • Galvez-Jimenez N, Lang AE. Perioperative problems in Parkinson’s disease and their management: apomorphine with rectal domperidone. Can J Neurol Sci. 1996;23(3):198–203.
  • Gordon MF. Toxin and drug-induced myoclonus. Adv Neurol. 2002;89:49–76.
  • Krauss JK, Akeyson EW, Giam P, et al. Propofol-induced dyskinesias in Parkinson’s disease. Anesth Analg. 1996;83(2):420–422.
  • Mets B. Acute dystonia after alfentanil in untreated Parkinson’s disease. Anesth Analgesia. 1991;72(4):557–558.
  • Klausner, J.M., Caspi J, Lelcuk S, et al. Delayed muscular rigidity and respiratory depression following fentanyl anesthesia. Arch Surg. 1988;123(1):66.
  • Brooks DE. Propofol-induced movement disorders. Ann Emerg Med. 2008;51(1):111–112.
  • Katus L, Shtilbans A. Perioperative management of patients with Parkinson’s disease. Am J Med. 2014;127(4):275–280.
  • Shaikh SI, Verma H. Parkinson’s disease and anaesthesia. Indian J Anaesth. 2011;55(3):228–234.
  • Mantz J, Varlet C, Lecharny JB, et al. Effects of volatile anesthetics, thiopental, and ketamine on spontaneous and depolarization-evoked dopamine release from striatal synaptosomes in the rat. Anesthesiology. 1994;80(2):352–363.
  • Zesiewicz TA, Hauser RA, Freeman A, et al. Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease. Clin Neuropharmacol. 2009;32(1):48–50.
  • Akbar U, Dham B, He Y, et al. Incidence and mortality trends of aspiration pneumonia in Parkinson’s disease in the United States, 1979-2010. Parkinsonism Relat Disord. 2015;21(9):1082–1086.
  • Friedman JH, McCool FD, Sherman CB. Shortness of breath in Parkinson’s disease. Parkinsonism Relat Disord. 2011;17(6):495.
  • Umehara T, Matsuno H, Toyoda C, et al. Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res. 2016;26(1):15–21.
  • Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, et al. Orthostatic hypotension in Parkinson disease: how much you fall or how low you go? Move Disord. 2015;30(5):639–645.
  • McGrane S, Atria NP, Barwise JA. Perioperative implications of the patient with autonomic dysfunction. Curr Opin Anaesthesiol. 2014;27(3):365–370.
  • Haensch CA, Lerch H, Jörg J, et al. Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson’s disease. Parkinsonism Relat Disord. 2009;15(2):134–137.
  • Pérez T, Tijero B, Gabilondo I, et al. Cardiocirculatory manifestations in Parkinson’s disease patients without orthostatic hypotension. J Hum Hypertens. 2015;29(10):604–609.
  • Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–245.
  • Orimo S, Suzuki M, Inaba A, et al. 123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18(5):494–500.
  • Shin DH, Lee PH, Bang OY, et al. Clinical implications of cardiac-MIBG SPECT in the differentiation of Parkinsonian syndromes. J Clin Neurol. 2006;2(1):51–57.
  • Akbar U, Friedman JH. Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease. Expert Rev Neurother. 2015;15(9):1053–1065.
  • Whitlock EL, Vannucci A, Avidan MS. Postoperative delirium. Minerva Anestesiol. 2011;77(4):448–456.
  • Robinson TN, Raeburn CD, Tran ZV, et al. Postoperative delirium in the elderly: risk factors and outcomes. Ann Surg. 2009;249(1):173–178.
  • Vardy ER, Teodorczuk A, Yarnall AJ. Review of delirium in patients with Parkinson’s disease. J Neurol. 2015;262(11):2401–2410.
  • Lubomski M, Rushworth RL, Tisch S. Hospitalisation and comorbidities in Parkinson’s disease: a large Australian retrospective study. J Neurol Neurosurg Psychiatry. 2015;86(3):324–330.
  • Carlson JD, Neumiller JJ, Swain LDW, et al. Postoperative delirium in Parkinson’s disease patients following deep brain stimulation surgery. J Clin Neurosci. 2014;21(7):1192–1195.
  • Golden WE, Lavender RC, Metzer WS. Acute postoperative confusion and hallucinations in Parkinson disease. Ann Intern Med. 1989;111(3):218–222.
  • Boorsma M, Joling KJ, Frijters DHM, et al. The prevalence, incidence and risk factors for delirium in Dutch nursing homes and residential care homes. Int J Geriatr Psychiatry. 2012;27(7):709–715.
  • Hack N, Fayad SM, Monari EH, et al. An eight-year clinic experience with clozapine use in a Parkinson’s disease clinic setting. PLoS One. 2014;9(3):e91545.
  • Nadelson M, Sanders R, Avidan M. Perioperative cognitive trajectory in adults. Br J Anaesth. 2014;112(3):440–451.
  • Baranov D, Bickler PE, Crosby GJ, et al. Consensus statement: first international workshop on anesthetics and Alzheimer’s disease. Anesth Analg. 2009;108(5):1627–1630.
  • Avidan, M.S., Searleman AC, Storandt M, et al. Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness. J Am Soc Anesthesiologists. 2009;111(5):964–970.
  • Avidan MS, Evers AS. Review of clinical evidence for persistent cognitive decline or incident dementia attributable to surgery or general anesthesia. J Alzheimers Dis. 2011;24(2):201–216.
  • Rodriguez-Raecke R, Niemeier A, Ihle K, et al. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neuroscience. 2009;29(44):13746–13750.
  • Hudetz JA, Gandhi SD, Iqbal Z, et al. Elevated postoperative inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery. J Anesth. 2011;25(1):1–9.
  • Chen C-W, Lin -C-C, Chen K-B, et al. Increased risk of dementia in people with previous exposure to general anesthesia: A nationwide population-based case–control study. Alzheimer’s & Dementia. 2014;10(2):196–204.
  • Chen P-L, Yang C-W, Tseng Y-K, et al. Risk of dementia after anaesthesia and surgery. Br J Psychiatry. 2014;204(3):188–193.
  • Sprung, J., Jankowski CJ, Roberts RO, et al. Anesthesia and incident dementia: a population-based, nested, case-control study. In: Mayo clinic proceedings. Elsevier; 2013;88(3):552–561.
  • Sztark F, Le Goff M, André D, et al. Exposure to general anaesthesia could increase the risk of dementia in elderly: 18AP1‐4. Eur J Anaesthesiology (EJA). 2013;30:245–245.
  • Radtke F, Franck M, Lendner J, et al. Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth. 2013;110(suppl 1):i98–i105.
  • Medtronic I, Medtronic DBS therapy, information for prescribers. Available from: http://manuals.medtronic.com/wcm/groups/mdtcom_sg/@emanuals/@era/@neuro/documents/documents/contrib_229535.pdf, 2014.
  • Medtronic I, Electrocautery/surgery standard letter. Available from: https://professional.medtronic.com/wcm/groups/mdtcom_sg/@mdt/@neuro/documents/documents/dbs-electrocautery-letter.pdf, 2014.
  • Friedman JH, Hospitalization of a Parkinson’s patient. American Parkinson Disease Association, 1995. Available from: http://www.apdaparkinson.org/uploads/files/05_rev2011-9PE.pdf.
  • Aminoff MJ, Christine CW, Friedman JH, et al. Management of the hospitalized patient with Parkinson’s disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011;17(3):139–145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.